A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges

Dry eye syndrome (DES) or keratoconjunctivitis sicca (KCS) is a common disorder of the tear film caused by decreased tear production or increased evaporation and manifests with a wide variety of signs and symptoms. The present review from interpretation of the literature gives detailed information on the prevalence, definition, causes, diagnostic tests, and medical management of dry eye disease. A number of systems contribute to the physiological integrity of the ocular surface and disruption of system may or may not produce symptoms. Therefore accurate diagnosis of dry eyes with no or minimal disruption of physiological function is necessary. The paper also discusses different colloidal drug delivery systems and current challenges in the development of topical ophthalmic drug delivery systems for treatment of KCS. Due to the wide prevalence and number of factors involved, newer, more sensitive diagnostic techniques and novel therapeutic agents have been developed to provide ocular delivery systems with high therapeutic efficacy. The aim of this review is to provide awareness among the patients, health care professionals, and researchers about diagnosis and treatment of KCS and recent developments and future challenges in management of dry eye disease

Truth Discovery in Big Data Social Media Application

In this system first one is “misinformation spread” where a significant number of sources are contributing to false claims, making the identification of truthful claims difficult. For example, on, Instagram, rumors, Twitter scams, and influence bots are common examples of sources colluding, either intentionally or unintentionally, to spread misinformation and obscure the truth. The challenge is “data sparsity” or the “long-tail phenomenon” where a majority of sources only contribute a small number of claims, providing insufficient evidence to determine those sources’ trustworthiness. For example, in the Twitter datasets that we collected during real-world events, more than 90only contributed to a single claim. Third, many current solutions are not scalable to large-scale social sensing events because of the centralized nature of their truth discovery algorithms. We are going develop a Scalable and Robust Truth Discovery (SRTD) scheme to address the above all challenges. In this, the SRTD scheme jointly quantifies both the reliability of sources and the credibility of claims using a principled approach

Influence of esomeprazole on the pharmacodynamic activity of thiazolidinediones (pioglitazone and rosiglitazone) in animal models

Drug-drug interaction studies are essential building blocks in drug development. Thiazolidinediones (TZDs: pioglitazone, and rosiglitazone) are peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, which have been widely used in the treatment of type 2 diabetes as insulin sensitizers. Esomeprazole, the (S) -isomer of omeprazole, is the first proton pump inhibitor (PPI) developed as a single isomer for the treatment of acid-peptic disease by specific inhibition of H+K+- ATPase in gastric parietal cells. The role of esomeprazole on the pharmacodynamic activity of TZDs is not currently known; however, there is the possibility of drug interaction (DI) leading to decreased activity of TZDs. The study was planned to investigate the safety and effectiveness of TZDs therapy in the presence of esomeprazole in animal models

Influence of esomeprazole on the pharmacodynamic activity of thiazolidinediones (pioglitazone and rosiglitazone) in animal Models

Drug-drug interaction studies are essential building blocks in drug development. Thiazolidinediones (TZDs: pioglitazone, and rosiglitazone) are peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, which have been widely used in the treatment of type 2 diabetes as insulin sensitizers. Esomeprazole, the (S) -isomer of omeprazole, is the first proton pump inhibitor (PPI) developed as a single isomer for the treatment of acid-peptic disease by specific inhibition of H+K+- ATPase in gastric parietal cells. The role of esomeprazole on the pharmacodynamic activity of TZDs is not currently known; however, there is the possibility of drug interaction (DI) leading to decreased activity of TZDs. The study was planned to investigate the safety and effectiveness of TZDs therapy in the presence of esomeprazole in animal models

Article A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges

Dry eye syndrome (DES) or keratoconjunctivitis sicca (KCS) is a common disorder of the tear film caused by decreased tear production or increased evaporation and manifests with a wide variety of signs and symptoms. The present review from interpretation of the literature gives detailed information on the prevalence, definition, causes, diagnostic tests, and medical management of dry eye disease. A number of systems contribute to the physiological integrity of the ocular surface and disruption of system may or may not produce symptoms. Therefore accurate diagnosis of dry eyes with no or minimal disruption of physiological function is necessary. The paper also discusses different colloidal drug delivery systems and current challenges in the development of topical ophthalmic drug delivery systems for treatment of KCS. Due to the wide prevalence and number of factors involved, newer, more sensitive diagnostic techniques and novel therapeutic agents have been developed to provide ocular delivery systems with high therapeutic efficacy. The aim of this review is to provide awareness among the patients, health care professionals, and researchers about diagnosis and treatment of KCS and recent developments and future challenges in management of dry eye disease

Spent graphite from end-of-life Li-ion batteries as a potential electrode for aluminium ion battery

Graphite is central in almost all commercial Li-ion batteries (LIBs) and possesses attractive physical and chemical properties such as good ionic conductivity and layered graphitic structure. In this communication, we have demonstrated the recycling of graphite from end-of-life LIBs and the re-purposing of the recovered material for positive electrodes in next-generation aluminium-ion-batteries (AIBs). The recovered graphite possesses enlarged interlayer spacing which is shown to effectively boost Al-ion insertion/de-insertion during the charge/discharge processes. Excellent Al-ion storage performance is achieved with the capacity reaching 124 mAh g⁻¹ at 50 mA g⁻¹. The material retained a capacity of 55 mAh g⁻¹ even after the applied current was increased to 500 mA g⁻¹, showing its capability to deliver high rate performance. The charge/discharge cycling further revealed that the graphite retains 81% of its initial capacity even after 6700 cycles at a high rate of 300 mA g⁻¹. This excellent aluminium ion storage performance makes the recovered graphite a promising positive electrode material, providing a possible solution for the recycling of huge amounts of LIB scrap. At the same time, this material aids the development of alternative sustainable battery technology, as an alternative to LIBs.Hong Duc Pham, Michael Horn, Joseph F.S. Fernando, Rohan Patil, Manisha Phadatare, Dmitri Golberg, Håkan Olin, Deepak P. Duba

Neutral wetting brush layers for block copolymer thin films using homopolymer blends processed at high temperatures

Binary homopolymer blends of two hydroxyl-terminated polystyrene (PS-OH) and polymethylmethacrylate (PMMA-OH) homopolymers (Mn similar to 16000 g mol(-1)) were grafted on SiO2 substrates by high-temperature (T > 150 degrees C), short-time (t < 600 s) thermal treatments. The resulting brush layer was tested to screen preferential interactions of the SiO2 substrate with the different symmetric and asymmetric PS-b-PMMA block copolymers deposited on top of the grafted molecules. By properly adjusting the blend composition and the processing parameters, an efficient surface neutralization path was identified, enabling the formation, in the block copolymer film, of homogeneous textures of lamellae or cylinders perpendicularly oriented with respect to the substrate. A critical interplay between the phase segregation of the homopolymer blends and their grafting process on the SiO2 was observed. In fact, the polar SiO2 is preferential for the PMMA-rich phase that forms a homogeneous layer on the substrate, while the PS-rich phase is located at the polymer-air interface. During the thermal treatment, phase segregation and grafting proceed simultaneously. Complete wetting of the PS rich phase on the PMMA rich phase leads to the formation of a PS/PMMA bilayer. In this case, the progressive diffusion of PS chains toward the polymer-SiO2 interface during the thermal treatment allows tuning of the brush layer composition

Neutral wetting brush layers for block copolymer thin films using homopolymer blends processed at high temperatures

Binary homopolymer blends of two hydroxyl-terminated polystyrene (PS-OH) and polymethylmethacrylate (PMMA-OH) homopolymers (Mn ∼ 16000 g mol(-1)) were grafted on SiO2 substrates by high-temperature (T > 150 °C), short-time (t < 600 s) thermal treatments. The resulting brush layer was tested to screen preferential interactions of the SiO2 substrate with the different symmetric and asymmetric PS-b-PMMA block copolymers deposited on top of the grafted molecules. By properly adjusting the blend composition and the processing parameters, an efficient surface neutralization path was identified, enabling the formation, in the block copolymer film, of homogeneous textures of lamellae or cylinders perpendicularly oriented with respect to the substrate. A critical interplay between the phase segregation of the homopolymer blends and their grafting process on the SiO2 was observed. In fact, the polar SiO2 is preferential for the PMMA-rich phase that forms a homogeneous layer on the substrate, while the PS-rich phase is located at the polymer-air interface. During the thermal treatment, phase segregation and grafting proceed simultaneously. Complete wetting of the PS rich phase on the PMMA rich phase leads to the formation of a PS/PMMA bilayer. In this case, the progressive diffusion of PS chains toward the polymer-SiO2 interface during the thermal treatment allows tuning of the brush layer composition

The Role of Acetyl Zingerone and Its Derivatives in Inhibiting UV-Induced, Incident, and Delayed Cyclobutane Pyrimidine Dimers

Cyclobutane pyrimidine dimers (CPDs) are ultraviolet radiation (UV)-induced carcinogenic DNA photoproducts that lead to UV signature mutations in melanoma. Previously, we discovered that, in addition to their incident formation (iCPDs), UV exposure induces melanin chemiexcitation (MeCh), where UV generates peroxynitrite (ONOO&macr;), which oxidizes melanin into melanin-carbonyls (MCs) in their excited triplet state. Chronic MeCh and energy transfer by MCs to DNA generates CPDs for several hours after UV exposure ends (dark CPD, dCPDs). We hypothesized that MeCh and the resulting dCPDs can be inhibited using MeCh inhibitors, and MC and ONOO&macr; scavengers. Here, we investigated the efficacy of Acetyl Zingerone (AZ), a plant-based phenolic alkanone, and its chemical analogs in inhibiting iCPDs and dCPDs in skin fibroblasts, keratinocytes, and isogenic pigmented and albino melanocytes. While AZ and its methoxy analog, 3-(4-Methoxy-benzyl)-Pentane-2,4-dione (MBPD) completely inhibited the dCPDs, MBPD also inhibited ~50% of iCPDs. This suggests the inhibition of ~80% of total CPDs at any time point post UV exposure by MBPD, which is markedly significant. MBPD downregulated melanin synthesis, which is indispensable for dCPD generation, but this did not occur with AZ. Meanwhile, AZ and MBPD both upregulated the expression of nucleotide excision repair (NER) pathways genes including Xpa, Xpc, and Mitf. AZ and its analogs were non-toxic to the skin cells and did not act as photosensitizers. We propose that AZ and MBPD represent &ldquo;next-generation skin care additives&rdquo; that are safe and effective for use not only in sunscreens but also in other specialized clinical applications owing to their extremely high efficacy in blocking both iCPDs and dCPDs

The Role of Acetyl Zingerone and Its Derivatives in Inhibiting UV-Induced, Incident, and Delayed Cyclobutane Pyrimidine Dimers

Cyclobutane pyrimidine dimers (CPDs) are ultraviolet radiation (UV)-induced carcinogenic DNA photoproducts that lead to UV signature mutations in melanoma. Previously, we discovered that, in addition to their incident formation (iCPDs), UV exposure induces melanin chemiexcitation (MeCh), where UV generates peroxynitrite (ONOO−), which oxidizes melanin into melanin-carbonyls (MCs) in their excited triplet state. Chronic MeCh and energy transfer by MCs to DNA generates CPDs for several hours after UV exposure ends (dark CPD, dCPDs). We hypothesized that MeCh and the resulting dCPDs can be inhibited using MeCh inhibitors, and MC and ONOO− scavengers. Here, we investigated the efficacy of Acetyl Zingerone (AZ), a plant-based phenolic alkanone, and its chemical analogs in inhibiting iCPDs and dCPDs in skin fibroblasts, keratinocytes, and isogenic pigmented and albino melanocytes. While AZ and its methoxy analog, 3-(4-Methoxy-benzyl)-Pentane-2,4-dione (MBPD) completely inhibited the dCPDs, MBPD also inhibited ~50% of iCPDs. This suggests the inhibition of ~80% of total CPDs at any time point post UV exposure by MBPD, which is markedly significant. MBPD downregulated melanin synthesis, which is indispensable for dCPD generation, but this did not occur with AZ. Meanwhile, AZ and MBPD both upregulated the expression of nucleotide excision repair (NER) pathways genes including Xpa, Xpc, and Mitf. AZ and its analogs were non-toxic to the skin cells and did not act as photosensitizers. We propose that AZ and MBPD represent “next-generation skin care additives” that are safe and effective for use not only in sunscreens but also in other specialized clinical applications owing to their extremely high efficacy in blocking both iCPDs and dCPDs